Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis

被引:165
作者
Giles, JT [1 ]
Bartlett, SJ [1 ]
Gelber, AC [1 ]
Nanda, S [1 ]
Fontaine, K [1 ]
Ruffing, V [1 ]
Bathon, JM [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2006年 / 55卷 / 02期
关键词
D O I
10.1002/art.21841
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:333 / 337
页数:5
相关论文
共 16 条
[11]
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].
Keane, J ;
Gershon, S ;
Wise, RP ;
Mirabile-Levens, E ;
Kasznica, J ;
Schwieterman, WD ;
Siegel, JN ;
Braun, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104
[12]
Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept [J].
Lee, JH ;
Slifman, NR ;
Gershon, SK ;
Edwards, ET ;
Schwieterman, WD ;
Siegel, JN ;
Wise, RP ;
Brown, SL ;
Udall, JN ;
Braun, MM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (10) :2565-2570
[13]
Experience with etanercept in an academic medical center: Are infection rates increased? [J].
Phillips, K ;
Husni, ME ;
Karlson, EW ;
Coblyn, JS .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (01) :17-21
[14]
POSS R, 1984, CLIN ORTHOP RELAT R, P117
[15]
INFECTION AS A COMPLICATION OF TOTAL KNEE-REPLACEMENT ARTHROPLASTY - RISK-FACTORS AND TREATMENT IN 67 CASES [J].
WILSON, MG ;
KELLEY, K ;
THORNHILL, TS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1990, 72A (06) :878-883
[16]
Management of infection associated with prosthetic joints [J].
Zimmerli, W ;
Ochsner, PE .
INFECTION, 2003, 31 (02) :99-108